RELIFERON 3MIU SDVL

About

Interferon alpha is a recombinant protein designed to replicate the functions of naturally occurring interferon alpha, a vital cytokine synthesized by the immune system primarily in response to viral infections and the presence of tumor cells. This potent biological agent exhibits a broad spectrum of pharmacological properties, including significant antiviral, antiproliferative, and immunomodulatory effects. Clinically, it is utilized in the treatment of chronic viral hepatitis B and C, various malignancies such as hairy cell leukemia, AIDS-related Kaposi's sarcoma, and as adjuvant therapy for malignant melanoma, among other indications. Its complex mechanism of action involves stimulating and enhancing the host's immune response, directly inhibiting viral replication within infected cells, and suppressing the uncontrolled proliferation of cancerous cells. Through these actions, interferon alpha plays a critical role in helping the body combat infections and effectively control the progression of specific diseases.

Uses

• Chronic Hepatitis B and C.
• Hairy Cell Leukemia.
• Kaposi's Sarcoma (AIDS-related).
• Malignant Melanoma (adjuvant therapy).

Directions For Use

Administered via subcutaneous or intramuscular injection, typically several times a week. Dosage and duration are determined by the specific condition and patient response.

Benefits

• Potent antiviral activity.
• Exhibits antiproliferative effects against cancer cells.
• Modulates and enhances immune responses.
• Can achieve sustained viral response in hepatitis.
• Effective in treating certain hematologic malignancies.
• Helps control disease progression in specific cancers.

Side Effects

• Flu-like symptoms (fever, chills, fatigue, muscle aches)
• Headache
• Nausea
• Vomiting
• Diarrhea
• Anorexia
• Weight loss
• Depression
• Irritability
• Thyroid dysfunction
• Myelosuppression (decreased blood counts)
• Injection site reactions

Safety Measures

• Alcohol - Avoid or limit alcohol consumption, especially in patients with hepatitis, as it can exacerbate liver damage and worsen side effects.
• Pregnancy - Contraindicated in pregnancy due to potential for fetal harm. Effective contraception is required during treatment.
• Breastfeeding - Not recommended during breastfeeding due to potential for serious adverse reactions in the infant.
• Liver - Use with caution in patients with pre-existing liver disease, and monitor liver function closely. Can cause or worsen hepatic decompensation.
• Kidney - Use with caution in patients with renal impairment; dosage adjustment may be necessary.
• Lung - Rare but serious pulmonary adverse events, including interstitial pneumonitis, have been reported. Monitor for respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.